Estimated Annual Spending on Lecanemab and Its Ancillary Costs in the US Medicare Program

被引：25

作者：

Arbanas, Julia Cave ^{[1
]}

Damberg, Cheryl L. ^{[2
]}

Leng, Mei ^{[1
]}

Harawa, Nina ^{[1
,3
]}

Sarkisian, Catherine A. ^{[1
,4
]}

Landon, Bruce E. ^{[5
,6
]}

Mafi, John N. ^{[1
,2
,7
]}

机构：

[1] Univ Calif Los Angeles, David Geffen Sch Med, Div Gen Internal Med & Hlth Serv Res, Los Angeles, CA USA

[2] RAND Corp, Santa Monica, CA USA

[3] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Los Angeles, CA USA

[4] VA Greater Los Angeles Healthcare Syst, Geriatr Res & Clin Ctr GRECC, Los Angeles, CA USA

[5] Harvard Med Sch, Boston, MA USA

[6] Beth Israel Deaconess Med Ctr, Div Gen Med, Boston, MA USA

[7] UCLA, David Geffen Sch Med, Div Gen Med & Hlth Serv Res, Dept Med, 1100 Glendon Ave,908, Los Angeles, CA 90024 USA

来源：

JAMA INTERNAL MEDICINE | 2023年 / 183卷 / 08期

关键词：

D O I：

10.1001/jamainternmed.2023.1749

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This cross-sectional cost analysis uses data from the 2018 Health and Retirement Study to estimate the potential future Medicare spending and beneficiary costs for lecanemab.

引用

页码：885 / 889

页数：5

共 6 条

[1] Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study [J].

Doraiswamy, P. M. ;

Sperling, R. A. ;

Johnson, K. ;

Reiman, E. M. ;

Wong, T. Z. ;

Sabbagh, M. N. ;

Sadowsky, C. H. ;

Fleisher, A. S. ;

Carpenter, A. ;

Joshi, A. D. ;

Lu, M. ;

Grundman, M. ;

Mintun, M. A. ;

Skovronsky, D. M. ;

Pontecorvo, M. J. .

MOLECULAR PSYCHIATRY, 2014, 19 (09) :1044-1051

[2] Cognitive Assessment At Medicare's Annual Wellness Visit In Fee-For-Service And Medicare Advantage Plans [J].

Jacobson, Mireille ;

Thunell, Johanna ;

Zissimopoulos, Julie .

HEALTH AFFAIRS, 2020, 39 (11) :1935-1942

[3] National estimates of the quantity and cost of informal caregiving for the elderly with dementia [J].

Langa, KM ;

Chernew, ME ;

Kabeto, MU ;

Herzog, AR ;

Ofstedal, MB ;

Willis, RJ ;

Wallace, RB ;

Mucha, LM ;

Straus, WL ;

Fendrick, AM .

JOURNAL OF GENERAL INTERNAL MEDICINE, 2001, 16 (11) :770-778

[4]

Liu J., 2017, Assessing the Preparedness of the U.S. Health Care System Infrastructure for an Alzheimer's Treatment, DOI [10.7249/RR2272, DOI 10.7249/RR2272]

[5] Estimated Annual Spending on Aducanumab in the US Medicare Program [J].

Mafi, John N. ;

Leng, Mei ;

Arbanas, Julia Cave ;

Tseng, Chi-Hong ;

Damberg, Cheryl L. ;

Sarkisian, Catherine ;

Landon, Bruce E. .

JAMA HEALTH FORUM, 2022, 3 (01) :E214495

[6]

van Dyck CH, 2023, NEW ENGL J MED, V388, P9, DOI [10.1056/NEJMoa2212948, 10.1056/NEJMc2301380]

← 1 →